AGPV (TFA)

CAT: 0804-HY-P3425ASize: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-P3425ASize:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

AGPV TFA, a tetrapeptide, has the potential for prevention of schistosome parasite infection research[1].

UNSPSC

12352209

Target

Parasite

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/agpv-tfa.html

Solubility

H2O

Smiles

CC(C)[C@@H](C(O)=O)NC([C@H]1N(CCC1)C(CNC([C@@H](N)C)=O)=O)=O.O=C(O)C(F)(F)F

Molecular Formula

C17H27F3N4O7

Molecular Weight

456.41

References & Citations

[1]James H. McKerrow, et al. Synthetic tetrapeptides for the prevention of schistosome parasite infection. US5284829A.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Isoform

Schistosome

Related Products